U.S. Drug Overdose Statistics: Deaths, Drugs, and Demographics

Final CDC mortality data recorded 79,384 drug overdose deaths in the United States in 2024, a decline from the previous year but still a major public health burden. The age-adjusted death rate fell from 31.3 deaths per 100,000 people in 2023 to 23.1 in 2024, according to the CDC National Center for Health Statistics.

Overdose statistics measure fatal events, nonfatal emergency care, toxicology findings, or provisional death reports. Each measure answers a different question. Accurate comparison requires the same definition, time period, population, and data status.

What is a drug overdose?

A drug overdose occurs when exposure to one or more substances causes life-threatening poisoning or death. The CDC mortality definition includes unintentional overdose, intentional self-poisoning, homicide, and cases where intent cannot be determined.

Fatal and nonfatal overdose data should not be combined. Death certificates support national mortality statistics; emergency department and emergency medical service records support nonfatal surveillance; toxicology data identify substances detected during an event. Clinical care uses these records differently from population research.

How many U.S. drug overdose deaths occurred in 2024?

According to the CDC, the United States recorded 79,384 drug overdose deaths in final 2024 data. According to the CDC, the corresponding crude rate was 23.3 deaths per 100,000 people and the age-adjusted rate was 23.1. Age adjustment supports comparison across populations with different age distributions.

The CDC reported that the age-adjusted rate decreased 26.2 percent from 2023 to 2024. The decline was the largest one-year percentage reduction during 2014 through 2024 and continued a decrease that began after 2022.

A national decline does not eliminate the need for overdose prevention, rapid clinical care, or treatment after a nonfatal event.

What do the latest provisional overdose estimates show?

Provisional estimates suggest that the national decline continued after the final 2024 data period. CDC data available for analysis on August 4, 2026 predicted 67,798 drug overdose deaths for the 12 months ending in March 2026, a 12.3 percent decline from the previous 12-month period.

Provisional counts change as death certificates arrive, causes are coded, and reporting becomes more complete. They should be labeled with their release date and should not be compared directly with final totals as though both datasets were complete.

Public health programs can use early signals to plan naloxone distribution and treatment access, while researchers wait for final mortality data before making fixed historical comparisons.

Which drugs were involved in the most overdose deaths?

Synthetic opioids other than methadone, a category driven largely by illegally made fentanyl, remained the leading reported drug category in 2024. According to CDC FastStats, 47,735 overdose deaths involved synthetic opioids other than methadone, 54,045 involved any opioid, and 2,743 involved heroin.

Stimulants also accounted for substantial mortality. According to the CDC data brief, 28,722 deaths involved psychostimulants with abuse potential, including methamphetamine, and 21,945 involved cocaine in 2024. These numbers cannot be added because one overdose death can appear in multiple drug categories.

According to CDC final mortality data, these drug categories were involved in U.S. overdose deaths during 2024.

Drug category	CDC final 2024 deaths	Interpretation
Any opioid	54,045	Includes prescription and illegally made opioids across several subcategories
Synthetic opioids other than methadone	47,735	Includes fentanyl, fentanyl analogs and tramadol
Psychostimulants with abuse potential	28,722	Includes methamphetamine, amphetamine and methylphenidate
Cocaine	21,945	May overlap with opioid and other drug involvement
Heroin	2,743	Reported separately from synthetic opioids

The substance pattern guides treatment and prevention: opioid exposure raises the need for naloxone and medications for opioid use disorder, while stimulant exposure requires its own clinical assessment and behavioral treatment plan.

How did overdose death rates change by drug type?

Rates declined across every opioid and stimulant category reported in the CDC's 2023-to-2024 comparison. According to the CDC, the age-adjusted rate involving synthetic opioids other than methadone fell 35.6 percent, from 22.2 to 14.3 deaths per 100,000 people.

According to the CDC, the psychostimulant-involved rate fell 19.8 percent, from 10.6 to 8.5, while the cocaine-involved rate fell 26.7 percent, from 8.6 to 6.3 deaths per 100,000 people. A falling rate shows improvement, but the remaining deaths still support prevention, treatment, and recovery services for people exposed to opioids and stimulants.

How did overdose death rates change by age and demographic group?

Overdose death rates declined from 2023 to 2024 for every age group and every race and Hispanic-origin group examined by the CDC. According to the CDC, the largest age-group decline occurred among people ages 15 through 24, whose rate fell 37.0 percent. Adults age 65 and older had the smallest decline at 8.8 percent.

The CDC reported the largest racial and ethnic group decline among non-Hispanic Black people. Rates remained higher for men than women in 2024, although both groups experienced decreases. Demographic rates describe population patterns and should guide equitable prevention and clinical access rather than assumptions about an individual.

How should state overdose statistics be compared?

State comparisons should use rates, data status, and reporting period rather than raw death counts alone. A larger state may record more deaths while having a lower population rate, and a provisional state estimate may change more than a final figure.

CDC dashboards provide state and jurisdiction filters for final mortality, provisional deaths, fatal-overdose circumstances, and nonfatal emergency care. State patterns also reflect drug supply, treatment access, naloxone distribution, rurality, housing, and reporting practices, so a rank by itself does not explain why risk differs.

What do intent and polysubstance involvement mean?

Most drug overdose deaths are unintentional, and many involve more than one substance. According to the CDC, 91.6 percent of 2024 overdose deaths were unintentional, 5.6 percent were suicides, 2.7 percent had undetermined intent, and fewer than 1 percent were homicides.

Polysubstance involvement can occur knowingly or unknowingly. Fentanyl may be present with cocaine, methamphetamine, heroin, counterfeit pills, benzodiazepines, or alcohol. Toxicology categories overlap, so a fentanyl-involved death and a cocaine-involved death may describe the same event rather than two deaths.

Clinical treatment should assess every substance involved because withdrawal risk, overdose risk, medication options, and recovery support differ across drug combinations.

What are the signs of an opioid overdose?

Opioid overdose signs include inability to awaken, slow or shallow breathing, choking or gurgling sounds, discolored lips or nails, and pinpoint pupils. When the cause is uncertain, treat an unresponsive person with abnormal breathing as a medical emergency.

Give naloxone when opioid overdose is possible, call 911, support breathing if trained, place the person on their side, and stay until emergency treatment arrives. Naloxone can restore breathing during an opioid overdose, repeat doses may be needed, and initial improvement does not replace emergency care.

What care is needed after a nonfatal overdose?

A nonfatal overdose requires medical evaluation, renewed overdose prevention, and rapid connection to treatment. Care should assess the substances involved, withdrawal, suicide risk, co-occurring mental health conditions, infection risk, pain, medications, housing, and the likelihood of another exposure.

Withdrawal can begin during observation or after discharge, and its risks depend on the substances involved. Opioid, alcohol, sedative, and stimulant withdrawal syndromes require different monitoring and treatment.

For opioid use disorder, treatment can include buprenorphine, methadone, or extended-release naltrexone along with behavioral and recovery support. Opioid addiction treatment can coordinate medication, therapy, relapse prevention, naloxone access, and continuing care after stabilization.

Are provisional overdose numbers final?

Provisional overdose numbers are not final because they reflect death records available at a stated point in time. Final mortality files complete additional processing and verification, while predicted provisional counts estimate deaths not yet fully reported.

Can drug-specific death counts be added together?

Drug-specific death counts cannot be added because one death may involve several drugs and appear in several categories. Adding opioid, cocaine, psychostimulant, or other involvement counts would count some deaths more than once.

Does naloxone work for every overdose?

Naloxone reverses opioid effects but does not reverse stimulant or sedative poisoning. A bystander can still give naloxone when opioid involvement is possible because illicit drug exposure is often uncertain.